Provided by Tiger Trade Technology Pte. Ltd.

CINGULATE INC.

6.82
-0.4000-5.54%
Pre-market: 7.300.4800+7.04%04:12 EST
Volume:276.10K
Turnover:1.96M
Market Cap:50.78M
PE:-1.34
High:7.40
Open:7.14
Low:6.80
Close:7.22
52wk High:7.92
52wk Low:3.20
Shares:7.45M
Float Shares:7.44M
Volume Ratio:0.54
T/O Rate:3.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1005
EPS(LYR):-10.1953
ROE:-275.85%
ROA:-106.65%
PB:14.62
PE(LYR):-0.67

Loading ...

Cingulate CEO Shane J. Schaffer Reports Acquisition of Common Shares

Reuters
·
10 hours ago

Cingulate Advances Capital Raise with Private Placement Financing

TIPRANKS
·
Feb 07

Cingulate Inc. Raises $6.5 Million in Private Placement of Unregistered Shares

Reuters
·
Feb 07

BRIEF-Cingulate Enters Securities Purchase Agreement For Private Placement Includes 2.14 Million Common Shares And 973 Preferred Shares

Reuters
·
Jan 29

Cingulate Announces Private Placement and New Preferred Stock

TIPRANKS
·
Jan 29

Cingulate Expands At-The-Market Equity Offering Capacity

TIPRANKS
·
Jan 16

BRIEF-Cingulate Inc Files For Mixed Shelf Offering Of Up To $200 Million- SEC Filing

Reuters
·
Jan 13

Cingulate files $200M mixed securities shelf

TIPRANKS
·
Jan 13

Cingulate Inc : Files for Mixed Shelf Offering of up to $200 Mln- SEC Filing

THOMSON REUTERS
·
Jan 13

Cingulate Inc. Issues Unregistered Shares to Lenders in Debt Exchange

Reuters
·
Jan 03

BRIEF- Shane Schaffer Reinstated As CEO Of Cingulate

Reuters
·
Dec 16, 2025

Cingulate Inc - Shane Schaffer Reinstated as CEO of Cingulate - SEC Filing

THOMSON REUTERS
·
Dec 15, 2025

Cingulate Inc: John Roberts Will No Longer Serve as Exec Chairman but Will Continue to Serve as Chairman of Board

THOMSON REUTERS
·
Dec 15, 2025

Cingulate Inc. Revises CEO Compensation Terms Following Administrative Leave

Reuters
·
Dec 15, 2025

Cingulate Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Dec 08, 2025

Cingulate Is Maintained at Buy by Roth Capital

Dow Jones
·
Nov 20, 2025

Cingulate price target lowered to $16 from $17 at Roth Capital

TIPRANKS
·
Nov 19, 2025

Cingulate Inc. Signs Exclusive Commercial Supply Agreement with Bend Bio Sciences

Reuters
·
Nov 19, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 17, 2025

Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment

TIPRANKS
·
Nov 16, 2025